These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma. Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337 [TBL] [Abstract][Full Text] [Related]
24. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299 [TBL] [Abstract][Full Text] [Related]
25. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid. Lu L; Zhou X; Wang J; Zheng SG; Horwitz DA PLoS One; 2010 Dec; 5(12):e15150. PubMed ID: 21179414 [TBL] [Abstract][Full Text] [Related]
26. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway. García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080 [TBL] [Abstract][Full Text] [Related]
27. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. Selvaraj RK; Geiger TL J Immunol; 2007 Jun; 178(12):7667-77. PubMed ID: 17548603 [TBL] [Abstract][Full Text] [Related]
28. TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway. Zhang Q; Cui F; Fang L; Hong J; Zheng B; Zhang JZ J Mol Cell Biol; 2013 Apr; 5(2):85-98. PubMed ID: 23243069 [TBL] [Abstract][Full Text] [Related]
29. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts. Yu Y; Huang R; Zong X; He X; Mo W BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040 [TBL] [Abstract][Full Text] [Related]
30. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells. Amarnath S; Dong L; Li J; Wu Y; Chen W Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698 [TBL] [Abstract][Full Text] [Related]
31. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. Pyzik M; Piccirillo CA J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784 [TBL] [Abstract][Full Text] [Related]
32. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. Moo-Young TA; Larson JW; Belt BA; Tan MC; Hawkins WG; Eberlein TJ; Goedegebuure PS; Linehan DC J Immunother; 2009 Jan; 32(1):12-21. PubMed ID: 19307989 [TBL] [Abstract][Full Text] [Related]
33. A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the Zhang Y; Liu W; Chen Y; Liu J; Wu K; Su L; Zhang W; Jiang Y; Zhang X; Zhang Y; Liu C; Tao L; Liu B; Zhang H J Immunol; 2018 Feb; 200(3):1053-1063. PubMed ID: 29282311 [TBL] [Abstract][Full Text] [Related]
34. Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy. Zheng Y; Lebid A; Chung L; Fu J; Wang X; Otrocol A; Zarif JC; Yu H; Llosa NJ; Pardoll DM Oncoimmunology; 2024; 13(1):2297503. PubMed ID: 38235319 [TBL] [Abstract][Full Text] [Related]
35. Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA. Kim J; Pena JV; McQueen HP; Kong L; Michael D; Lomashvili EM; Cook PR Cancer Gene Ther; 2024 Jan; 31(1):28-42. PubMed ID: 37990062 [TBL] [Abstract][Full Text] [Related]
36. Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis. Ghali JR; Alikhan MA; Holdsworth SR; Kitching AR Immunology; 2017 Jan; 150(1):100-114. PubMed ID: 27606831 [TBL] [Abstract][Full Text] [Related]
37. Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response. Shi F; Su J; Wang J; Liu Z; Wang T Mol Cell Biochem; 2021 Feb; 476(2):1015-1024. PubMed ID: 33141310 [TBL] [Abstract][Full Text] [Related]
38. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu. Hossain DM; Panda AK; Chakrabarty S; Bhattacharjee P; Kajal K; Mohanty S; Sarkar I; Sarkar DK; Kar SK; Sa G Immunology; 2015 Apr; 144(4):561-73. PubMed ID: 25284464 [TBL] [Abstract][Full Text] [Related]
39. Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells. Vaeth M; Schliesser U; Müller G; Reissig S; Satoh K; Tuettenberg A; Jonuleit H; Waisman A; Müller MR; Serfling E; Sawitzki BS; Berberich-Siebelt F Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16258-63. PubMed ID: 22991461 [TBL] [Abstract][Full Text] [Related]
40. CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β. Shahbaz S; Bozorgmehr N; Koleva P; Namdar A; Jovel J; Fava RA; Elahi S PLoS Biol; 2018 Dec; 16(12):e2006649. PubMed ID: 30550561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]